Our news – TeVido, an Austin biotech, has raised $1.2 million to help fund a new facility was featured in: “Outdoorsy’s Big Haul & Other Startup Fundraising in TX Tech News”
Summary – Let’s catch up with the latest innovation news in Texas.
TeVido, an Austin biotech, has raised $1.2 million to help fund a new facility in which the company can use a patient’s own cells to create personalized pigment cell grafts to treat vitiligo, a loss of skin color that affects about 1 percent of the world’s population. Investors included the Texas Halo Fund, the Central Texas Angel Network, and Life Science Angels. TeVido, which is commercializing technology from the University of Texas at El Paso, initially sought to use a breast cancer patient’s cell to create a more realistic nipple after reconstruction surgery.